← Open Payments lookup

SANDRA GATES-MANNA: Open Payments

NPI 1124396072 · GARY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,415 in 61 payments from 15 companies in 2025. Trend: 2023 $1,439 · 2024 $2,625 · 2025 $2,415

Food & beverage: $2,415
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$518
Axsome Therapeutics, Inc.6$358
ABBVIE INC.4$273
Abbott Laboratories15$253
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$235
Novo Nordisk Inc4$160
Eisai Inc.1$125
Kowa Pharmaceuticals America, Inc.1$121
Teva Pharmaceuticals USA, Inc.1$105
E.R. Squibb & Sons, L.L.C.1$89

Products named: AIRSUPRA, Auvelity, FREESTYLE LIBRE 3, VRAYLAR, CAPLYTA, Leqembi, Ozempic, ZORYVE.

Industry payments across IN — which companies pay providers there.